BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yu WX, Tang LN, Lin F, Yao Y, Shen Z. Comparison of pemetrexed plus cisplatin with gemcitabine plus docetaxel in refractory/metastatic osteosarcoma: Clinical outcomes from a retrospective database monitored in a single institute. Oncol Lett 2014;8:2243-8. [PMID: 25289103 DOI: 10.3892/ol.2014.2472] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Kasiram MZ, Hapidin H, Abdullah H, Ahmad A, Sulong S. Combination Therapy of Cisplatin and other Agents for Osteosarcoma: A Review. CCTR 2021;17:137-47. [DOI: 10.2174/1573394716999201016160946] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zhang Y, Yang J, Zhao N, Wang C, Kamar S, Zhou Y, He Z, Yang J, Sun B, Shi X, Han L, Yang Z. Progress in the chemotherapeutic treatment of osteosarcoma. Oncol Lett 2018;16:6228-37. [PMID: 30405759 DOI: 10.3892/ol.2018.9434] [Cited by in Crossref: 22] [Cited by in F6Publishing: 50] [Article Influence: 5.5] [Reference Citation Analysis]
3 Xu J, Guo W, Xie L. Combination of gemcitabine and docetaxel: a regimen overestimated in refractory metastatic osteosarcoma? BMC Cancer 2018;18:987. [PMID: 30326879 DOI: 10.1186/s12885-018-4872-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kim JH, Kim SH, Jeon MK, Kim JE, Kim KH, Yun KH, Jeung HC, Rha SY, Ahn JH, Kim HS. Pemetrexed plus cisplatin in patients with previously treated advanced sarcoma: a multicenter, single-arm, phase II trial. ESMO Open 2021;6:100249. [PMID: 34482181 DOI: 10.1016/j.esmoop.2021.100249] [Reference Citation Analysis]